{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Comparator+TIV&page=2", "query": { "intervention": "Comparator TIV", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Comparator+TIV&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-18T04:10:27.427Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04074928", "title": "Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Influenza", "Human", "Virus Diseases" ], "interventions": [ { "name": "QIVc", "type": "BIOLOGICAL" }, { "name": "Comparator QIV", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Seqirus", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Months", "maximum_age": "47 Months", "sex": "ALL", "summary": "6 Months to 47 Months" }, "enrollment_count": 2414, "start_date": "2019-09-06", "completion_date": "2020-09-03", "has_results": true, "last_update_posted_date": "2022-01-12", "last_synced_at": "2026-09-18T04:10:27.427Z", "location_count": 47, "location_summary": "Mobile, Alabama • Anaheim, California • Downey, California + 37 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Anaheim", "state": "California" }, { "city": "Downey", "state": "California" }, { "city": "Ontario", "state": "California" }, { "city": "Paramount", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04074928" }, { "nct_id": "NCT00979251", "title": "Oral Triple Combination Antiviral Drug Therapy for Treatment of Influenza A in Immunocompromised Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "Oseltamivir Phosphate", "type": "DRUG" }, { "name": "ADS-8902", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Adamas Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "65 Years", "sex": "ALL", "summary": "1 Year to 65 Years" }, "enrollment_count": 2, "start_date": "2009-09", "completion_date": "2011-08", "has_results": false, "last_update_posted_date": "2014-04-14", "last_synced_at": "2026-09-18T04:10:27.427Z", "location_count": 16, "location_summary": "San Francisco, California • Hollywood, Florida • Miramar, Florida + 11 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Hollywood", "state": "Florida" }, { "city": "Miramar", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00979251" }, { "nct_id": "NCT04956575", "title": "A Study of mRNA-1010 Seasonal Influenza Vaccine in Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Seasonal Influenza" ], "interventions": [ { "name": "mRNA-1010", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" }, { "name": "Active Comparator", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "ModernaTX, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 885, "start_date": "2021-07-06", "completion_date": "2022-09-27", "has_results": true, "last_update_posted_date": "2023-10-27", "last_synced_at": "2026-09-18T04:10:27.427Z", "location_count": 21, "location_summary": "Phoenix, Arizona • Tempe, Arizona • Colton, California + 17 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Colton", "state": "California" }, { "city": "Hollywood", "state": "Florida" }, { "city": "Savannah", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04956575" }, { "nct_id": "NCT01964989", "title": "Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of Investigational Flu Vaccine Compared to Approved Flu Vaccine in Children.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Influenza Virus" ], "interventions": [ { "name": "Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV)", "type": "BIOLOGICAL" }, { "name": "Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Seqirus", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Months", "maximum_age": "71 Months", "sex": "ALL", "summary": "6 Months to 71 Months" }, "enrollment_count": 10644, "start_date": "2013-11", "completion_date": "2016-08", "has_results": true, "last_update_posted_date": "2023-03-27", "last_synced_at": "2026-09-18T04:10:27.427Z", "location_count": 91, "location_summary": "Chandler, Arizona • Harrisburg, Arkansas • Anaheim, California + 70 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Harrisburg", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Anaheim", "state": "California" }, { "city": "Baldwin Park", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01964989" }, { "nct_id": "NCT06602531", "title": "Safety and Immunogenicity Study of Self-Amplifying RNA Pandemic Influenza Vaccine in Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Influenza, Human" ], "interventions": [ { "name": "ARCT-2304", "type": "BIOLOGICAL" }, { "name": "Control vaccine younger adults", "type": "BIOLOGICAL" }, { "name": "Control vaccine older adults", "type": "BIOLOGICAL" }, { "name": "Placebo Vaccine", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Arcturus Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 212, "start_date": "2024-12-10", "completion_date": "2025-12-05", "has_results": true, "last_update_posted_date": "2026-09-04", "last_synced_at": "2026-09-18T04:10:27.427Z", "location_count": 4, "location_summary": "La Mesa, California • San Bernardino, California • Longmont, Colorado + 1 more", "locations": [ { "city": "La Mesa", "state": "California" }, { "city": "San Bernardino", "state": "California" }, { "city": "Longmont", "state": "Colorado" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06602531" }, { "nct_id": "NCT02914275", "title": "A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 6 Months Through 59 Months of Age.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Influenza, Human" ], "interventions": [ { "name": "Seqirus Quadrivalent Inactivated Influenza Vaccine", "type": "BIOLOGICAL" }, { "name": "Comparator Quadrivalent Inactivated Influenza Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Seqirus", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Months", "maximum_age": "59 Months", "sex": "ALL", "summary": "6 Months to 59 Months" }, "enrollment_count": 2250, "start_date": "2016-09-27", "completion_date": "2017-08-11", "has_results": true, "last_update_posted_date": "2019-01-23", "last_synced_at": "2026-09-18T04:10:27.427Z", "location_count": 39, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Anaheim, California + 27 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Anaheim", "state": "California" }, { "city": "Anaheim", "state": "California" }, { "city": "Downey", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02914275" }, { "nct_id": "NCT07726862", "title": "How Healthy Adults Respond to the Nasal Flu Vaccine", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Mucosal Immune Response to Influenza Vaccination" ], "interventions": [ { "name": "FluMist (Live Attenuated Influenza Vaccine)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 20, "start_date": "2026-10-01", "completion_date": "2031-06-30", "has_results": false, "last_update_posted_date": "2026-07-24", "last_synced_at": "2026-09-18T04:10:27.427Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT07726862" }, { "nct_id": "NCT05045144", "title": "A Phase III Study to Assess the Lot-to-lot Consistency of GSK's Investigational RSV Maternal Vaccine and the Immune Response and Safety of RSV Maternal Vaccine When Given Alone or Co-administered With GSK's Influenza D-QIV Vaccine in Healthy Non-pregnant Women.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Respiratory Syncytial Virus Infections" ], "interventions": [ { "name": "RSVPreF3(120 μg)", "type": "COMBINATION_PRODUCT" }, { "name": "Flu Quadrivalent influenza vaccine (15 μg HA)", "type": "COMBINATION_PRODUCT" }, { "name": "Placebo", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "FEMALE", "summary": "18 Years to 49 Years · Female only" }, "enrollment_count": 1586, "start_date": "2021-10-26", "completion_date": "2022-06-06", "has_results": true, "last_update_posted_date": "2023-10-05", "last_synced_at": "2026-09-18T04:10:27.427Z", "location_count": 5, "location_summary": "West Palm Beach, Florida • Stockbridge, Georgia • Peoria, Illinois + 2 more", "locations": [ { "city": "West Palm Beach", "state": "Florida" }, { "city": "Stockbridge", "state": "Georgia" }, { "city": "Peoria", "state": "Illinois" }, { "city": "Springfield", "state": "Missouri" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT05045144" }, { "nct_id": "NCT07204964", "title": "A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Influenza, Human" ], "interventions": [ { "name": "Flu mRNA (Formulation B1)", "type": "BIOLOGICAL" }, { "name": "Flu mRNA (Formulation B3)", "type": "BIOLOGICAL" }, { "name": "Flu mRNA(Formulation A)", "type": "BIOLOGICAL" }, { "name": "Comparator 1", "type": "COMBINATION_PRODUCT" }, { "name": "Comparator 2", "type": "COMBINATION_PRODUCT" }, { "name": "Comparator 3", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "BIOLOGICAL", "COMBINATION_PRODUCT" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 971, "start_date": "2025-10-07", "completion_date": "2026-07-31", "has_results": false, "last_update_posted_date": "2026-03-27", "last_synced_at": "2026-09-18T04:10:27.427Z", "location_count": 15, "location_summary": "Guntersville, Alabama • Canoga Park, California • Walnut Creek, California + 12 more", "locations": [ { "city": "Guntersville", "state": "Alabama" }, { "city": "Canoga Park", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07204964" }, { "nct_id": "NCT00664417", "title": "Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Influenza", "Orthomyxoviridae Infections" ], "interventions": [ { "name": "Monovalent subvirion H5N1 influenza vaccine", "type": "BIOLOGICAL" }, { "name": "Physiological saline", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 375, "start_date": "2008-04", "completion_date": "2010-08", "has_results": false, "last_update_posted_date": "2012-04-17", "last_synced_at": "2026-09-18T04:10:27.427Z", "location_count": 6, "location_summary": "San Diego, California • South Miami, Florida • Springfield, Missouri + 2 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "South Miami", "state": "Florida" }, { "city": "Springfield", "state": "Missouri" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00664417" } ] }